![Eugene Marcantonio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eugene Marcantonio
Algemeen Directeur bij ARMGO Pharma, Inc.
Profiel
Eugene Marcantonio is currently the Chief Executive Officer & Director at ARMGO Pharma, Inc. He has been in this position since 2021.
Prior to his current role, Eugene obtained a doctorate degree from New York University School of Medicine.
Actieve functies van Eugene Marcantonio
Bedrijven | Functie | Begin |
---|---|---|
ARMGO Pharma, Inc.
![]() ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2021 |
Opleiding van Eugene Marcantonio
New York University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ARMGO Pharma, Inc.
![]() ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |